{"transactions":[{"id":2933883,"issuer":{"id":7878,"kind":"organization","name":"GT Biopharma, Inc."},"owners":[{"id":144449,"kind":"person","name":"Weldon Steven W","position":1,"cik":"0001356710","reported_name":"Weldon Steven W","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Officer and Director"}}],"security":"Common Stock","published_at":"2020-12-23T21:24:42.000Z","date":"2020-12-22","kind":"sale","acquired":false,"shares":47978,"price":0.4,"value":19191.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2020."}],"balance_after":3720000,"source":{"system":"sec-edgar","filing":"0001356710-20-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/109657/000135671020000003/primary_doc.xml","form_type":"4"}},{"id":2933882,"issuer":{"id":7878,"kind":"organization","name":"GT Biopharma, Inc."},"owners":[{"id":144449,"kind":"person","name":"Weldon Steven W","position":1,"cik":"0001356710","reported_name":"Weldon Steven W","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Officer and Director"}}],"security":"Common Stock","published_at":"2020-12-23T21:24:42.000Z","date":"2020-12-21","kind":"sale","acquired":false,"shares":35722,"price":0.34,"value":12145.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2020."}],"balance_after":3767978,"source":{"system":"sec-edgar","filing":"0001356710-20-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/109657/000135671020000003/primary_doc.xml","form_type":"4"}},{"id":2933881,"issuer":{"id":7878,"kind":"organization","name":"GT Biopharma, Inc."},"owners":[{"id":144449,"kind":"person","name":"Weldon Steven W","position":1,"cik":"0001356710","reported_name":"Weldon Steven W","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Officer and Director"}}],"security":"Common Stock","published_at":"2020-12-23T21:24:42.000Z","date":"2020-12-21","kind":"sale","acquired":false,"shares":50000,"price":0.33,"value":16500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2020."}],"balance_after":3803700,"source":{"system":"sec-edgar","filing":"0001356710-20-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/109657/000135671020000003/primary_doc.xml","form_type":"4"}},{"id":2933880,"issuer":{"id":7878,"kind":"organization","name":"GT Biopharma, Inc."},"owners":[{"id":144449,"kind":"person","name":"Weldon Steven W","position":1,"cik":"0001356710","reported_name":"Weldon Steven W","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Officer and Director"}}],"security":"Common Stock","published_at":"2020-12-23T21:24:42.000Z","date":"2020-12-21","kind":"sale","acquired":false,"shares":50000,"price":0.3,"value":15000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2020."}],"balance_after":3853700,"source":{"system":"sec-edgar","filing":"0001356710-20-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/109657/000135671020000003/primary_doc.xml","form_type":"4"}},{"id":2938843,"issuer":{"id":7878,"kind":"organization","name":"GT Biopharma, Inc."},"owners":[{"id":144449,"kind":"person","name":"Weldon Steven W","position":1,"cik":"0001356710","reported_name":"Weldon Steven W","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Officer and Director"}}],"security":"Common Stock","published_at":"2020-12-18T21:24:01.000Z","date":"2020-12-18","kind":"sale","acquired":false,"shares":50000,"price":0.3,"value":15000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":". The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2020."}],"balance_after":3903700,"source":{"system":"sec-edgar","filing":"0001356710-20-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/109657/000135671020000002/primary_doc.xml","form_type":"4"}},{"id":2938842,"issuer":{"id":7878,"kind":"organization","name":"GT Biopharma, Inc."},"owners":[{"id":144449,"kind":"person","name":"Weldon Steven W","position":1,"cik":"0001356710","reported_name":"Weldon Steven W","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Officer and Director"}}],"security":"Common Stock","published_at":"2020-12-18T21:24:01.000Z","date":"2020-12-17","kind":"sale","acquired":false,"shares":50000,"price":0.31,"value":15500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":". The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2020."}],"balance_after":3953700,"source":{"system":"sec-edgar","filing":"0001356710-20-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/109657/000135671020000002/primary_doc.xml","form_type":"4"}},{"id":2938841,"issuer":{"id":7878,"kind":"organization","name":"GT Biopharma, Inc."},"owners":[{"id":144449,"kind":"person","name":"Weldon Steven W","position":1,"cik":"0001356710","reported_name":"Weldon Steven W","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Officer and Director"}}],"security":"Common Stock","published_at":"2020-12-18T21:24:01.000Z","date":"2020-12-17","kind":"sale","acquired":false,"shares":50000,"price":0.3,"value":15000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":". The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2020."}],"balance_after":4003700,"source":{"system":"sec-edgar","filing":"0001356710-20-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/109657/000135671020000002/primary_doc.xml","form_type":"4"}},{"id":2938840,"issuer":{"id":7878,"kind":"organization","name":"GT Biopharma, Inc."},"owners":[{"id":144449,"kind":"person","name":"Weldon Steven W","position":1,"cik":"0001356710","reported_name":"Weldon Steven W","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Officer and Director"}}],"security":"Common Stock","published_at":"2020-12-18T21:24:01.000Z","date":"2020-12-16","kind":"sale","acquired":false,"shares":50000,"price":0.3,"value":15000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":". The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2020."}],"balance_after":4053700,"source":{"system":"sec-edgar","filing":"0001356710-20-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/109657/000135671020000002/primary_doc.xml","form_type":"4"}},{"id":2945620,"issuer":{"id":7878,"kind":"organization","name":"GT Biopharma, Inc."},"owners":[{"id":144449,"kind":"person","name":"Weldon Steven W","position":1,"cik":"0001356710","reported_name":"Weldon Steven W","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Officer and Director"}}],"security":"Common Stock","published_at":"2020-12-15T22:40:31.000Z","date":"2020-12-15","kind":"sale","acquired":false,"shares":50000,"price":0.32,"value":16000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2020."}],"balance_after":4103700,"source":{"system":"sec-edgar","filing":"0001356710-20-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/109657/000135671020000001/primary_doc.xml","form_type":"4"}},{"id":2945619,"issuer":{"id":7878,"kind":"organization","name":"GT Biopharma, Inc."},"owners":[{"id":144449,"kind":"person","name":"Weldon Steven W","position":1,"cik":"0001356710","reported_name":"Weldon Steven W","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Officer and Director"}}],"security":"Common Stock","published_at":"2020-12-15T22:40:31.000Z","date":"2020-12-15","kind":"sale","acquired":false,"shares":50000,"price":0.3,"value":15000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2020."}],"balance_after":4153700,"source":{"system":"sec-edgar","filing":"0001356710-20-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/109657/000135671020000001/primary_doc.xml","form_type":"4"}},{"id":2945618,"issuer":{"id":7878,"kind":"organization","name":"GT Biopharma, Inc."},"owners":[{"id":144449,"kind":"person","name":"Weldon Steven W","position":1,"cik":"0001356710","reported_name":"Weldon Steven W","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Officer and Director"}}],"security":"Common Stock","published_at":"2020-12-15T22:40:31.000Z","date":"2020-12-15","kind":"sale","acquired":false,"shares":50000,"price":0.3,"value":15000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2020."}],"balance_after":4203700,"source":{"system":"sec-edgar","filing":"0001356710-20-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/109657/000135671020000001/primary_doc.xml","form_type":"4"}},{"id":2945617,"issuer":{"id":7878,"kind":"organization","name":"GT Biopharma, Inc."},"owners":[{"id":144449,"kind":"person","name":"Weldon Steven W","position":1,"cik":"0001356710","reported_name":"Weldon Steven W","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Officer and Director"}}],"security":"Common Stock","published_at":"2020-12-15T22:40:31.000Z","date":"2020-12-14","kind":"sale","acquired":false,"shares":46300,"price":0.29,"value":13427.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2020."}],"balance_after":4253700,"source":{"system":"sec-edgar","filing":"0001356710-20-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/109657/000135671020000001/primary_doc.xml","form_type":"4"}},{"id":2945616,"issuer":{"id":7878,"kind":"organization","name":"GT Biopharma, Inc."},"owners":[{"id":144449,"kind":"person","name":"Weldon Steven W","position":1,"cik":"0001356710","reported_name":"Weldon Steven W","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Officer and Director"}}],"security":"Common Stock","published_at":"2020-12-15T22:40:31.000Z","date":"2020-12-14","kind":"sale","acquired":false,"shares":50000,"price":0.29,"value":14500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2020."}],"balance_after":4300000,"source":{"system":"sec-edgar","filing":"0001356710-20-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/109657/000135671020000001/primary_doc.xml","form_type":"4"}},{"id":2945615,"issuer":{"id":7878,"kind":"organization","name":"GT Biopharma, Inc."},"owners":[{"id":144449,"kind":"person","name":"Weldon Steven W","position":1,"cik":"0001356710","reported_name":"Weldon Steven W","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Officer and Director"}}],"security":"Common Stock","published_at":"2020-12-15T22:40:31.000Z","date":"2020-12-14","kind":"sale","acquired":false,"shares":50000,"price":0.28,"value":14000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2020."}],"balance_after":4350000,"source":{"system":"sec-edgar","filing":"0001356710-20-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/109657/000135671020000001/primary_doc.xml","form_type":"4"}},{"id":2945614,"issuer":{"id":7878,"kind":"organization","name":"GT Biopharma, Inc."},"owners":[{"id":144449,"kind":"person","name":"Weldon Steven W","position":1,"cik":"0001356710","reported_name":"Weldon Steven W","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Officer and Director"}}],"security":"Common Stock","published_at":"2020-12-15T22:40:31.000Z","date":"2020-12-11","kind":"sale","acquired":false,"shares":50000,"price":0.26,"value":13000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2020."}],"balance_after":4400000,"source":{"system":"sec-edgar","filing":"0001356710-20-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/109657/000135671020000001/primary_doc.xml","form_type":"4"}},{"id":2945613,"issuer":{"id":7878,"kind":"organization","name":"GT Biopharma, Inc."},"owners":[{"id":144449,"kind":"person","name":"Weldon Steven W","position":1,"cik":"0001356710","reported_name":"Weldon Steven W","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Former Officer and Director"}}],"security":"Common Stock","published_at":"2020-12-15T22:40:31.000Z","date":"2020-12-11","kind":"sale","acquired":false,"shares":50000,"price":0.25,"value":12500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2020."}],"balance_after":4450000,"source":{"system":"sec-edgar","filing":"0001356710-20-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/109657/000135671020000001/primary_doc.xml","form_type":"4"}},{"id":3150010,"issuer":{"id":7878,"kind":"organization","name":"GT Biopharma, Inc."},"owners":[{"id":144449,"kind":"person","name":"Weldon Steven W","position":1,"cik":"0001356710","reported_name":"Weldon Steven W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"common stock","published_at":"2020-05-14T17:40:35.000Z","date":"2020-05-13","kind":"sale","acquired":false,"shares":2269708,"price":0.001,"value":2269.708,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The disposal of the 2,269,708 shares was made to satisfy obligations pursuant to the terms of a Stock Pledge Agreement signed on August 1, 2018."}],"balance_after":4500000,"source":{"system":"sec-edgar","filing":"0000939798-20-000006","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/109657/000093979820000006/primary_doc.xml","form_type":"4"}},{"id":3436949,"issuer":{"id":7878,"kind":"organization","name":"GT Biopharma, Inc."},"owners":[{"id":144449,"kind":"person","name":"Weldon Steven W","position":1,"cik":"0001356710","reported_name":"Weldon Steven W","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CFO"}}],"security":"common stock","published_at":"2019-08-16T20:51:22.000Z","date":"2019-08-14","kind":"grant","acquired":true,"shares":4500000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6769707,"source":{"system":"sec-edgar","filing":"0000939798-19-000030","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/109657/000093979819000030/primary_doc.xml","form_type":"4"}},{"id":4146950,"issuer":{"id":7878,"kind":"organization","name":"GT Biopharma, Inc."},"owners":[{"id":144449,"kind":"person","name":"Weldon Steven W","position":1,"cik":"0001356710","reported_name":"Weldon Steven W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"common stock","published_at":"2017-12-01T22:17:36.000Z","date":"2017-09-01","kind":"grant","acquired":true,"shares":2566835,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2568840,"source":{"system":"sec-edgar","filing":"0000939798-17-000099","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/109657/000093979817000099/primary_doc.xml","form_type":"4"}}]}